A 25-year perspective on advances in the study of the epidemiology, disparities, and outcomes of urologic cancers.
Administrative data set
Electronic health record
Epidemiology
Outcomes research
Urology
Journal
Urologic oncology
ISSN: 1873-2496
Titre abrégé: Urol Oncol
Pays: United States
ID NLM: 9805460
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
received:
17
02
2021
revised:
22
03
2021
accepted:
23
03
2021
pubmed:
4
5
2021
medline:
21
1
2022
entrez:
3
5
2021
Statut:
ppublish
Résumé
In this narrative review, key developments in epidemiologic and clinical outcomes-based research from eminent historical data sources over the past quarter century are summarized. We then describe the rise of secondary and administrative datasets (AD), summarizing the predominant types of available secondary datasets for contemporary research and describe the benefits and inherent limitations in working with secondary data. We review the methodological advances that permit researchers to capitalize on the full capability of secondary data while also addressing the limitations inherent in utilizing these data for the purposes of epidemiologic and outcomes research. Finally, we present candidate strategies to perpetuate this momentum towards optimizing the development of clinical research infrastructure that harnesses the full potential of the ADs to further clinical and epidemiological research, advancing data analysis, and address the many unanswered questions that remain.
Identifiants
pubmed: 33934967
pii: S1078-1439(21)00129-0
doi: 10.1016/j.urolonc.2021.03.019
pii:
doi:
Types de publication
Historical Article
Journal Article
Research Support, N.I.H., Extramural
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
595-601Subventions
Organisme : NCI NIH HHS
ID : P30 CA072720
Pays : United States
Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.